Trump’s New Executive Order Aims to Slash Drug Costs by Aligning with Global Prices
May 12, 2025 – In a move to lower prescription drug costs for Americans, former President Donald Trump signed an executive order (EO) directing federal agencies to align U.S. drug prices with those paid by other nations. According to a White House fact sheet, Americans currently pay more than three times what other countries do for brand-name medications.
This marks Trump’s second major drug pricing EO in recent months. In April, he signed another order targeting high pharmaceutical costs through Medicare reforms and industry regulations. However, experts caution that these changes may take time to implement, meaning immediate relief for consumers is unlikely.
Key Provisions of the Executive Order
The latest EO outlines several aggressive measures to reduce drug prices, including: